Novo Nordisk A/S ADR buy Haans
Start price
16.02.16
/
50%
€44.57
Target price
11.04.16
€58.00
Performance (%)
12.12%
End price
11.04.16
€49.11
Summary
This prediction ended on 11.04.16 with a price of €49.11. The BUY prediction by Haans finished with a performance of 12.12%. Haans has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | -1.167% | -1.167% | -33.681% | -60.923% |
| iShares Core DAX® | -1.875% | 2.861% | 18.863% | 63.672% |
| iShares Nasdaq 100 | -2.177% | 0.048% | 3.956% | 109.562% |
| iShares Nikkei 225® | -0.867% | 6.987% | 21.062% | 54.912% |
| iShares S&P 500 | -1.253% | 1.248% | 2.246% | 69.801% |
Comments by Haans for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Trendaktie...
Diabetis ist noch wohl noch lange im Trend. Auch die Abott sollte man sich näher anschauen.
(Vom Mitglied beendet)
Stopped prediction by Haans for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€41.58
24.08.16
24.08.16
€50.00
24.02.17
24.02.17
-19.18%
24.02.17
24.02.17
